Department of Health Home A to Z Topics About the Department of Health Site Map Contact Us - Opens in a new window

Epidemiology Home

Health Topics (A-Z)

Related Links

Contact Us

   

DOHLOGO.GIF (7396 bytes)

EPI UPDATE

A weekly publication by the Bureau of Epidemiology

"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."

--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.

For August 6, 1999

Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist

Don Ward, Surveillance Section Administrator, Epi Update Managing Editor

Jill H. Parker, MSP, Epi Update Editor

Bureau of Epidemiology Frequent Contributors:

Steven Wiersma, MD, MPH,

Deputy State Epidemiologist

William J. Bigler, PhD, MS,

Senior Epidemiologist

Jodi Baldy, MPH,

Biological Scientist IV

Ursula E. Bauer, PhD,

Chronic Disease Epidemiologist

John Werth, MA,

Bureau Education Coordinator

Lisa Conti, DVM, MPH,

State Public Health Veterinarian

Regional Epidemiologists:

Dolly Katz, PhD, MPH,

SE Florida

Roger Sanderson, RN, MA,

SW Florida

Carina Blackmore, MS Vet. Med., PhD, NE Florida

Zuber Mulla, MSPH,

Central Florida

Gérard Krause, MD, DTMH,

NW Florida

Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.

The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.

The Department of Health has a home on the World Wide Web at --- http://www.doh.state.fl.us

 

In this issue:

1. Outbreaks of Influenza-like Illness in Florida Correctional Facilities

2. Pertussis: A Continuing Concern

3. Streptococcus pneumoniae Case Report Forms

4. Educational Opportunities: Principles of Epidemiology Distance Learning Course Begins September 10, 1999

5. Florida Past: Physicians, Medical Ethics and Public Health

6. Weekly Disease Table: Week 30

 

1. Outbreaks of Influenza-like Illness in Florida Correctional Facilities

Zuber D. Mulla, MSPH; Carina Blackmore, MSVetMed, PhD;

Lillian Stark, PhD, MS, MPH; Girija Padmanabh, MD, MPH; and, Janice Warnock, SRNS

Summer outbreaks of influenza in the United States have been previously documented [1,2]. The Miami-Dade County Health Department recently reported an outbreak of influenza-like illness (ILI) in a state correctional facility [3]. We report on three additional summer outbreaks of ILI in Florida correctional facilities.

Correctional Facility A:

On July 14, 1999, the DOH Bureau of Epidemiology (Northeast Florida Regional Office) received a phone call from an infection control nurse at a correctional reception center in north Florida. The facility was experiencing an outbreak of ILI (case definition for this outbreak: fever of ³ 100 degrees plus a cough or sore throat). The attack rate in inmates between July 2 and July 27 was 3.7% (81/2200). The attack rate in staff (both security and medical department staff) during this period was 0.3% (3/1000).

Correctional Facility B:

On July 21, 1999, the Florida Department of Health (DOH), Bureau of Epidemiology (Central Florida Regional Office) received a phone call from the nursing supervisor of a state correctional facility. Several inmates were experiencing an acute, febrile respiratory illness. The duration of illness was approximately four days and resolved without the use of antibiotics. The illness appeared to be influenza. The Sumter County Health Department was notified immediately. The correctional facility’s nursing supervisor was advised to isolate affected wings, prevent staff from working on multiple wings, exclude ill staff and visitors, and promote hand washing. Isolation was impossible. The majority of inmates are housed in a common dormitory, and they interact frequently in this hall and during recreational periods. Inmates are constantly transferred into and out of this facility.

Influenza vaccination is offered to inmates annually. Staff members, however, do not receive free influenza vaccinations.

For the purposes of this investigation, a case of ILI was defined as an inmate or staff member who had fever plus a sore throat or cough with an onset between July 14 and July 29, 1999. The epidemic curve of ILI in inmates is shown below (see attached Excel file). The gentle up-slope and steep tail indicates person-to-person spread. Between July 14 and July 29, there were 120 cases of ILI identified (115 inmates and 5 medical department staff). The attack rate in inmates was 6.8% (115/1701). The attack rate in medical department staff was 26.3% (5/19). Surveillance was not conducted in the remaining staff members.

Viral culturettes were sent from the DOH Tampa Branch Laboratory to the facility. Six inmates who were acutely ill (onset within last 72 hours) were swabbed, and the samples were received at the Tampa Branch Laboratory on July 27. On August 2, the Laboratory isolated influenza virus from two of the six throat swabs. The isolates were identified as influenza A (H3N2) serotype by a hemagglutination inhibition assay.

PrisonFlu.gif (4551 bytes)

Correctional Facility C:

On July 21, 1999, the DOH Bureau of Epidemiology (Northeast Florida Regional Office) received a phone call from a state correctional facility in north Florida. The facility reported that an outbreak of ILI was in progress (case definition for this outbreak: fever of ³ 100 degrees plus a cough or sore throat). Initially, the cases were found in two dormitories. The attack rate from July 17 through July 31 was 3.8% in inmates (32/850) and 25% in medical staff (3/12). Pharyngeal swabs were collected from two inmates and sent to the DOH Central Laboratory in Jacksonville for influenza virus isolation. The results were negative.

In conclusion, influenza should be considered as a potential etiologic agent during summer outbreaks of acute respiratory illness. The influenza A serotype isolated from Correctional Facility A inmates (type H3N2) was the same serotype that was found in an outbreak of ILI in a Dade County correctional facility in late June of 1999 [3]. The source(s) of the outbreaks documented in this report is unknown but may have been this south Florida facility. The continual transfer of inmates from facility to facility provides ample opportunity for transmission of infection throughout the state. The dissemination of ILI in Florida’s state prison system during this summer includes at least two other correctional facilities that have identified ILI in inmates in July and August of 1999.

References

  1. CDC. Influenza A infection – Florida and Tennessee, July – August 1998, and virologic surveillance of influenza, May—August 1998. MMWR, September 18, 1998; 47:756-9.
  2. CDC. Outbreak of influenza A infection among travelers – Alaska and the Yukon Territory, May—June 1999. MMWR, July 2, 1999; 48:545,546,555.
  3. Cruz M, Trepka MJ, and Katz D. Dade County influenza-like illness outbreak in a correctional facility. Epi Update 1999; July 15. SEE ERATUM IN JULY 23, 1999 ISSUE (Editor’s Corner)

2. Pertussis: A Continuing Concern

Phyllis Yambor, Community Health Nursing Consultant, Bureau of Immunization

Pertussis remains an acute endemic, highly contagious disease caused by the Bordetella pertussis bacterium. In Florida, pertussis or whooping cough is the most frequently reported vaccine-preventable disease. There were 64 culture confirmed-cases of pertussis in 1997, 39 in 1998 and 40 year to date for 1999. Incidence for 1999 year-to-date was highest in infants less than one year of age (23 cases). A majority of those cases occurred in infants less than 6 months of age (21) who were too young to have either begun or completed 3 doses of vaccine.

Following an incubation period of 6-20 days, the clinical picture often begins with mild upper respiratory symptoms that progress to an illness characterized by episodes of paroxysmal coughing followed by a characteristic whoop, apnea and post-tussive vomiting. The disease may last 6 to 10 weeks and usually confers immunity. Complications may include pneumonia, otitis media and rarely, seizures, encephalopathy and death. Communicability is high in the early catarrhal stage and continues for 3 weeks following the onset of the paroxysmal cough or for 5 days following treatment. Pertussis is more severe for infants less than one year of age and often requires hospitalization. The at-risk infant often acquires the infection from an older sibling or adult in the household. Pertussis in adolescents and young adults may be due to a waning of immunity from childhood immunization. Pertussis in adults and older children often goes undiagnosed as they may be asymptomatic, have mild symptoms or are treated for the presenting symptoms such as bronchitis without benefit of culture.

Prompt case identification is imperative in order to treat the case and thereby decrease the period of communicability. Contact identification and antimicrobial prophylaxis will further reduce the spread of pertussis. Case confirmation is accomplished by culture with isolation of B. pertussis from a clinical specimen or positive polymerase chain reaction (PCR). The direct immunofluorescent assay (DFA) can provide presumptive diagnosis but is not reliable for lab confirmation.

The following is an example of the communicability of pertussis. Eleven confirmed cases have been reported from one county. These cases occurred in a close-knit extended family, of which many refuse immunizations due to personal religious beliefs. Symptomatic contacts of the first reported culture positive case, an infant, were cultured prior to prophylaxis, and eight of those contacts were culture confirmed.

Immunization against pertussis is the best prevention. Prior to the availability of the pertussis vaccine in the 1940s, pertussis was one of the most common childhood diseases and a major cause of mortality in the United States with over 200,000 cases reported annually. Following the introduction and widespread use of the pertussis vaccine, incidence has decreased more than 98% since 1980; cases now average about 3,700 per year. There is an apparent 3-5 year cycle observed with pertussis, which may explain increases in reported cases in 1992-1993 and 1996. The vaccine, in combination with diphtheria and tetanus, is recommended for children aged 2 months through 6 years. A more purified acellular pertussis vaccine that is associated with decreased adverse events was licensed for the fourth and fifth doses in 1991 and for infants in 1996.

References

1. National Immunization Program, Centers for Disease Control and Prevention, Council of State and Territorial Epidemiologists, Manual for the Surveillance of Vaccine-Preventable Diseases. September 1997. 8-1.

2. American Public Health Association. Control of Communicable Diseases in Man. Washington D.C., 1995.

3. Streptococcus pneumoniae Case Report Forms

Streptococcus pneumoniae case report forms will be sent to each county health department next week. The forms will also be available to download from the DOH Internet web site. 

4. Educational Opportunities: Principles of Epidemiology Distance Learning Course Begins September 10, 1999

John F. Werth, MA, Bureau Education Coordinator

Session 3 of the CDC distance learning course entitled "Principles of Epidemiology" (CDC SS3030) will be offered through the Bureau of Epidemiology beginning September 10, 1999. The home-study course is targeted to county health department staff. The course will span three months and will require extensive reading, active participation in a weekly conference call, and a final exam.

Curricula will include concepts, principles, and general methods used in the surveillance and investigation of disease-related events; key features and applications of descriptive and analytic epidemiology; the processes, uses, and evaluation of public health surveillance; and methods of investigating an outbreak.

Professional education credits are offered for the successful completion of this course. The CDC accredits this course for CME’s of 42 hours and CEU’s of 42 hours (4.2 units). Bureau staff will provide guidance and support throughout the course.

Prior sessions of this home-study course were very successful. Thirty participants enrolled in Session 1 and twenty-six (87%) of them passed the final exam. Session 2 had 18 participants enrolled and we expect similar or better test results. Again, we congratulate their fine efforts and thank Local County Health Department Directors/Administrators for their support.

Conference Call / Lesson Schedule

Lesson 1

Introduction to Epidemiology

Dolores Katz

Sept. 10

Lesson 2

Frequency Measures Used in Epidemiology

Lisa Conti

Sept. 17 & 24

Lesson 3

Measures of Central Location and Dispersion

Carina Blackmore

Oct. 8 & 15

Lesson 4

Organizing Epidemiological Data

Gérard Krause

Oct. 22 & 29

Lesson 5

Public Health Surveillance

Zuber Mulla

Nov. 5 & 12

Lesson 6

Investigating an Outbreak

Roger Sanderson

Nov. 19 & Dec. 3

Review

All Chapters All Instructors

Dec. 10

Final Exam/CDC - Distributed December 10

To be returned

December 31

 

Registration Selection Criteria:

  • Sponsorship of CHD Director/Administrator required (E-mail preferred, or memorandum)
  • County health department (CHD) staff member performs ongoing epidemiological functions
  • Limit of one staff member from each CHD per session
  • Maximum enrollment of 16 participants each course offering
  • Commitment to attend all audio-conference sessions and complete the final exam

For additional information or registration materials, please contact John Werth, MA.

5. FLORIDA PAST – Physicians, Medical Ethics and Public Health

William J. Bigler, PhD

In April 1941 , Walter C. Jones, Jr. M.D., the new President of the Florida Medical Association, delivered his first public address before the Jacksonville Kiwanis Club. The topic of his presentation was "The Aim of Medical Ethics is to protect Patients." In reviewing the "generally accepted standards of ethics governing the relation between doctors, themselves and their patients and society" he made special mention of the role of physicians and public health. Excerpts from an abstract printed in the July 1941 issue of Florida Health Notes follow:

"The physician has an important relationship to the community. It is his duty to give advice concerning public health matters. He should assist in the enforcement of laws of public health and should be ready to counsel the public on public hygiene and legal medicine, quarantine regulations and the prevention of epidemics and contagious diseases. In cases of epidemics or extreme emergency it is his duty to labor without regard to risk of his own health or life, or concern as to financial returns. For further protection of public health all cases of communicable diseases are required to be reported to the public health authorities. These duties are self explanatory but mean much to society’s welfare.

"The physician should warn the public against various devices which may be injurious to health or may even result in loss of life, and it is further his duty to exert every effort to legally protect the public against such devices. The medical profession of the State of Florida at the last session of the legislature was able to enact such a law, - a law which is of no monetary value to them but is a protection to the public health by requiring all who practice the healing art to have knowledge of the basic sciences.

"These are only a few of the principles involved in the relationship of the physician to himself, the patient and society. As Walt Whitman stated, 'In the end nothing services but personal character' and the underlying basis of all ethics is that one should constantly behave toward others as he desires them to deal with him."

6. Weekly Disease Table - Week 30

County-Confirmed Cases, Sorted Alphabetically by Disease

NR represents years that the disease lacked status as a reportable condition

DISEASE

1996 TO DATE

1997 TO DATE

1998 TO DATE

3 YEAR AVERAGE TO DATE

1998 TOTAL CASES

1999 TO DATE

Amebiasis

40

32

34

35.3

91

27

Anthrax

0

0

0

0

0

0

Botulism

0

0

0

0

0

0

Brucellosis

5

0

1

2

3

0

Campylobacteriosis

639

536

413

529.3

975

502

Ciguatera

8

2

6

5.3

7

2

Cryptosporidiosis

77

57

68

67.3

203

64

Cyclosporiasis

163

57

5

75

6

2

Dengue

0

1

1

0.7

5

2

Diphtheria

0

0

0

0

0

0

E. coli O157:H7

11

31

17

19.7

56

28

E. coli, other (known serotype)

2

5

2

3

12

12

Ehrlichiosis, Human

4

2

0

2

1

2

Encephalitis, Eastern Equine

0

0

0

0

0

0

Encephalitis, St. Louis

0

0

0

0

2

0

Encephalitis, other (known organism)

3

6

3

4

7

2

Encephalitis, post-infectious*

11

5

5

7

21

4

Giardiasis (acute)

883

772

674

776.3

1636

554

Haemophilus influenzae*, invasive

12

12

26

16.7

45

27

Hansen’s Disease (Leprosy)

1

0

3

1.3

4

2

Hantavirus Infection

0

0

0

0

0

0

Hemolytic Uremic Syndrome

0

2

3

1.7

12

6

Hemorrhagic Fever

0

0

0

0

0

0

Hepatitis A

241

245

287

257.7

539

360

Hepatitis B

283

205

209

232.3

466

232

Hepatitis Non-A, Non-B

41

51

50

47.3

95

6

Hepatitis, unspecified

2

3

4

3

26

10

Lead Poisoning

1072

755

937

921.3

1805

372

Legionellosis

18

14

21

17.7

48

16

Leptospirosis

0

0

1

0.3

2

0

Lyme Disease

6

13

20

13

71

14

Malaria

42

40

31

37.7

96

48

Measles

1

3

2

2

2

1

Meningococcal Disease (N. meningitidis)

125

95

80

100

133

70

Meningitis, Group B Streptococci

15

10

11

12

22

8

Meningitis, Haemophilus influenzae

4

6

9

6.3

12

10

Meningitis, Streptococcus pneumoniae

65

49

55

56.3

96

68

Meningitis, Listeria monocytogenes

4

2

4

3.3

13

5

Meningitis, other bacterial (including unspecified)

60

33

33

42

75

42

Mercury Poisoning

5

2

0

2.3

4

2

Mumps

4

8

9

7

11

2

Neurotoxic Shellfish Poisoning

0

0

0

0

0

0

Pertussis

53

42

23

39.3

39

44

Pesticide Poisoning

1

0

1

0.7

1

3

Plague

0

0

0

0

0

0

Poliomyelitis

0

0

0

0

0

0

Psittacosis

0

0

1

0.3

2

0

Rabies, Animal

128

176

119

141

215

104

Rocky Mountain Spotted Fever

1

2

1

1.3

2

2

Rubella, including congenital

10

0

3

4.3

4

0

Salmonellosis

1088

942

1054

1028

3038

1181

Shigellosis

783

620

1140

847.7

2343

776

Streptococcal Disease, invasive Group A

0

24

27

17.0

57

51

Streptococcus pneumoniae, Drug Resistant

1

125

284

136.7

493

370

Tetanus

1

0

2

1.0

3

1

Toxic Shock Syndrome

0

1

3

1.3

4

3

Toxoplasmosis

6

3

6

5.0

15

8

Typhoid Fever

11

5

10

8.7

16

21

Vibrio cholerae (serogrp O1)

0

0

0

0

0

0

Vibrio cholerae (serogrp Non-O1)

1

6

6

4.3

11

5

Vibrio vulnificus

6

6

13

8.3

35

6

Vibrio other (including unspecified)

11

19

43

24.3

73

24

Yellow Fever

0

0

0

0

0

0

*Haemophilus influenzae can be the agent responsible for disease under three of the reportable conditions listed-:

"Haemophilus influenzae, invasive" and under "Encephalitis, post infectious." Cases of Haemophilus influenzae meningitis are reported under

"Meningitis, H. influenzae."

Editor's Note: Kawasaki Disease, Histoplasmosis, Reye Syndrome, and Typhus were deleted from the weekly disease table since cases are no longer reportable.

This page was last modified on: 10/25/2012 11:00:54